Literature DB >> 12869835

The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000.

Robert Peck1, Daniel W Fitzgerald, Bernard Liautaud, Marie Marcelle Deschamps, Rose Irene Verdier, Marie Eugene Beaulieu, Reynold GrandPierre, Patrice Joseph, Patrice Severe, Francine Noel, Peter Wright, Warren D Johnson, Jean William Pape.   

Abstract

BACKGROUND: HIV voluntary counseling and testing (VCT) may be an effective strategy to prevent transmission of HIV in developing countries. Hypothesizing that primary care services and HIV VCT have synergistic benefits, we examine the feasibility, the demand, and the effect of integrating on-site primary care services into VCT at a stand-alone VCT center in Port au Prince, Haiti.
METHODS: Through a retrospective review of patient records, we describe the integration of primary care services at the Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) VCT center between1985 and 2000.
RESULTS: Between 1985 and 1999, services for HIV care, tuberculosis care, treatment of sexually transmitted diseases, and reproductive health were sequentially integrated into HIV VCT at GHESKIO. The number of new people seeking voluntary counseling and testing at GHESKIO increased from 142 in 1985 to 8175 in 1999, with an increasing percentage of women, adolescents, symptom-free clients, and self-referred clients. Of new adults seeking VCT in 1999, the center was able to provide AIDS care to 17%, tuberculosis treatment to 6%, sexually transmitted infection management to 18%, and family planning to 19%. HIV transmission between discordant couples was 0 infections/100 follow-up years (95% CI, 0-3.2); vertical transmission from mother to child was 11 infections/100 live births (95% CI, 4.6-21.9); These rates are significantly lower than expected rates of transmission in Haiti.
CONCLUSIONS: This report demonstrates the feasibility, demand, and effective synergy of integrating on-site primary care services into HIV VCT in Haiti. VCT is a good entry point for people in need of services for communicable diseases and reproductive health, and, reciprocally, services attract more people to VCT, including populations that are at high risk for HIV infection. This program is being duplicated elsewhere in Haiti and can serve as a model for other countries.

Entities:  

Mesh:

Year:  2003        PMID: 12869835     DOI: 10.1097/00126334-200308010-00007

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  29 in total

1.  Successes and challenges of HIV treatment programs in Haiti: aftermath of the earthquake.

Authors:  S Koenig; Lc Ivers; S Pace; R Destine; F Leandre; R Grandpierre; J Mukherjee; Pe Farmer; Jw Pape
Journal:  HIV Ther       Date:  2010-03

2.  Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.

Authors:  Patrice Severe; Marc Antoine Jean Juste; Alex Ambroise; Ludger Eliacin; Claudel Marchand; Sandra Apollon; Alison Edwards; Heejung Bang; Janet Nicotera; Catherine Godfrey; Roy M Gulick; Warren D Johnson; Jean William Pape; Daniel W Fitzgerald
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

3.  Cost-effectiveness of free HIV voluntary counseling and testing through a community-based AIDS service organization in Northern Tanzania.

Authors:  Nathan M Thielman; Helen Y Chu; Jan Ostermann; Dafrosa K Itemba; Anna Mgonja; Sabina Mtweve; John A Bartlett; John F Shao; John A Crump
Journal:  Am J Public Health       Date:  2005-11-29       Impact factor: 9.308

4.  Improving national data collection systems from voluntary counselling and testing centres in Kenya.

Authors:  Kennedy N Otwombe; John Wanyungu; Kilonzo Nduku; Miriam Taegtmeyer
Journal:  Bull World Health Organ       Date:  2007-04       Impact factor: 9.408

5.  Determinants of HIV serostatus disclosure to sexual partner among HIV-positive alcohol users in Haiti.

Authors:  Donaldson F Conserve; Gary King; Jessy G Dévieux; Michèle Jean-Gilles; Robert Malow
Journal:  AIDS Behav       Date:  2014-06

6.  Maternal HIV illness and its impact on children well-being and development in Haiti.

Authors:  Donaldson F Conserve; Eddy Eustache; Catherine M Oswald; Ermaze Louis; Fiona Scanlan; Joia S Mukherjee; Pamela J Surkan
Journal:  J Child Fam Stud       Date:  2014-12-09

7.  The Haiti research-based model of international public health collaboration: the GHESKIO Centers.

Authors:  Jean W Pape; Patrice D Severe; Daniel W Fitzgerald; Marie M Deschamps; Patrice Joseph; Cynthia Riviere; Vanessa Rouzier; Warren D Johnson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

8.  Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals.

Authors:  Macarthur Charles; Francine Noel; Paul Leger; Patrice Severe; Cynthia Riviere; Carole Anne Beauharnais; Erica Miller; John Rutledge; Heejung Bang; Wesley Shealey; Richard T D'Aquila; Roy M Gulick; Warren D Johnson; Peter F Wright; Jean William Pape; Daniel W Fitzgerald
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

9.  Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique - a case study.

Authors:  James Pfeiffer; Pablo Montoya; Alberto J Baptista; Marina Karagianis; Marilia de Morais Pugas; Mark Micek; Wendy Johnson; Kenneth Sherr; Sarah Gimbel; Shelagh Baird; Barrot Lambdin; Stephen Gloyd
Journal:  J Int AIDS Soc       Date:  2010-01-20       Impact factor: 5.396

10.  Fertility goal-based counseling increases contraceptive implant and IUD use in HIV-discordant couples in Rwanda and Zambia.

Authors:  Naw H Khu; Bellington Vwalika; Etienne Karita; William Kilembe; Roger A Bayingana; Deborah Sitrin; Heidi Roeber-Rice; Emily Learner; Amanda C Tichacek; Lisa B Haddad; Kristin M Wall; Elwyn N Chomba; Susan A Allen
Journal:  Contraception       Date:  2012-11-12       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.